The serum concentrations of individual fractions however are not equally reduced, as rates of synthesis diff er for each protein. Albumin and gamma-globulin concentrations are typically the most depressed while fi brinogen and alpha2-marcoglobulin may be normal [5, 16, 20, 24] . As medium chain triglycerides (MCTs) are absorbed directly into the portal blood stream, they bypass and therefore reduce the pressure in the lymphatic system of the gut [18, 25] . In combination with a low fat diet, this has now become the main method of treating the symptoms of most patients with intestinal lymphangiectasia, although there are other therapeutic options, both pharmacological and surgical, which have been employed in specifi c circumstances [25 -29] . We describe three patients treated at our Institution and review the evidence for the effi cacy of a low fat MCT diet. The engorged lymphatics rupture and discharge their contents into the lumen of the bowel, resulting in a non-specifi c protein loss [16 -20] 
Introduction &
Primary intestinal lymphangiectasia is an uncommon congenital abnormality of the lymphatics of the gut, characterised by steatorrhoea, hypoalbuminaemia and oedema.Although there were several reports in the literature of patients aff ected by an " idiopathic hypoproteinaemia " [1 -3] , it was not until 1961 that Waldmann et al. [4] defi nitively described the clinical features and the histological appearance of dilated lymphatics of the mucosa and submucosa. They suggested the term " intestinal lymphangiectasia " to refl ect the characteristic pathological appearance [1] . The other clinical, biochemical and haematological features are listed in • ▶ Table 1 [4 -15] .
The engorged lymphatics rupture and discharge their contents into the lumen of the bowel, resulting in a non-specifi c protein loss [16 -20] . When this exceeds the maximum synthetic capacity of the body, hypoproteinaemia ensues [16, 20 -23] .
Primary intestinal lymphangiectasia is an uncommon congenital anomaly. It is an intrinsic abnormality of the intestinal lymphatics system. Over the years, various treatment options such as diuretics, albumin transfusions and a medium chain triglycerides (MCT) diet as well as surgical options such as resection of isolated segments and peritoneal-venous shunts have been used. An MCT diet, which is a low fat, high protein diet, is increasingly used in the management of this anomaly. Aim: The aim was to review the evidence for medium chain triglycerides as a therapeutic option in patients with primary intestinal lymphangiectasia. Material and Methods: A literature search was performed and individual case details were extracted. We found 55 cases, of which 3 were from our own institute. The cases were divided in 2 groups: Group A (n = 27) consisted of patients treated with MCT, and Group B (n = 28) consisted patients not treated with MCT. Cases were analysed for symptomatic response to MCT as well as mortality. Results: 17 of 27 cases (63 % ) treated with MCT had complete resolution of symptoms while only 10 of 28 (35.7 % ) patients in group B showed complete resolution. Mortality for Group A was 1 out of 27 (3.7 % ), while mortality in group B was 5 of 28 (17.85 % ) patients. Conclusion: We conclude that, although an MCT diet is not completely curative in all cases, it does improve the symptoms of primary intestinal lymphangiectasia and reduces mortality. Hence it is a valid option in the paediatric age group. 
Methods &
The case notes of two contemporary patients and one identifi ed from the archives were reviewed. A MEDLINE and a manual literature search were performed to identify publications on primary intestinal lymphangiectasia (IL). Where possible, details of the cases were extracted and combined, giving a total of 55 patients. If there was any doubt about the diagnosis or whether the IL was primary or secondary, these cases were omitted. Two groups emerged: those treated with MCT (x = 24 + 3) and those treated without MCT (y = 28 patients). The outcome in each case was determined as complete remission of symptoms, some improvement of symptoms with improved quality of life, no improvement, or death. We attempted to look at other aspects such as response in relation to age at presentation and presenting symptoms but encountered some diffi culties due to the variable levels of details included in the case reports.
Case Reports

& Case 1
A male child was noted at birth to have a swollen right arm but otherwise appeared healthy. He was routinely referred to the surgical team who agreed that he probably had Milroy ' s disease. One year later he was admitted with anorexia, weight loss, vomiting and diarrhoea which did not respond to a gluten or lactose free diet. Over the next nine months on the ward his routine investigations were normal apart from low plasma proteins (values not available) and an I 131 -albumin study which confi rmed a protein-losing enteropathy. He was eventually taken for laparotomy where he was noted to have gross thickening of the entire small bowel. A biopsy demonstrated intestinal lymphangiectasia. He responded to a high protein, low fat and low carbohydrate diet and was discharged.( • ▶ Fig. 1 -4 ).
Two months later, he was readmitted with further diarrhoea, abdominal distension, worsening oedema of his limb and tetany. He had low plasma albumin levels and hypocalcaemia which responded to calcium chloride, calciferol 600,000 iu, chlorthiazide 250 mg tds and potassium chloride 0.5 g bd. He was maintained on this regime with only minor alterations through a regular outpatient review until the age of eight years when a medium chain triglyceride diet was introduced. At this point his weight paralleled the 10 th centile, his height was in the 3rd centile and his bone age in the 25 th centile. Over a one year period his peripheral oedema and ascites decreased. However there was no objective evidence for increased growth velocity and his weight fell to the 3rd centile, which may have been related to the decreased peripheral oedema and ascites. The dose of MCT was increased and a moderate increase in growth velocity was subsequently noted. He developed asthma then defaulted for several years, returning with recurrent chest infections. He was no longer on the diet but had minimal symptoms and was 5 feet tall. At age 18 years his diarrhoea recurred and his diet was reinstated. He did not have signifi cant functional impairments as a result of the oedema and managed to fi nd work as a printer. Shortly afterwards he was discharged in the care of an adult physician. He is still alive at time of writing but we are unaware of his current clinical state.
Case 2
A male child was delivered by spontaneous vaginal delivery at term with a swollen right arm and left leg. He was referred to the surgical clinic where swelling of the right side of his face was additionally noted. Ultrasounds of his head and abdomen were normal. Through the local lymphoedema clinic, pressure garments were obtained but these initially had little eff ect. He required surgery for a large umbilical hernia and phimosis; histopathology reported dilated lymphatics in the excised skin specimens. At the age of two years he was noted to have a protein-losing enteropathy and an abdominal mass which was lobulated and displacing the bowel on MRI. He was experiencing recurrent upper respiratory tract infections and had low IgG (5.1 g / l), IgA (0.2 g / l) and T-cells. PCP chemoprophylaxis was introduced. A neck node biopsy was reported as lymphangiectasia. Over a six month period, the abdominal mass continued to enlarge and a contrast enhanced CT-scan displayed a mass extending from the renal arteries to the pelvis which was displacing the bowel. It also found a right pleural eff usion and lymphoedema of the azygo-oesophageal recess, small bowel and its mesentery. A debulking laparotomy was attempted. There were chylous ascites, a thickened small bowel and an extensive diff use mass of small bowel mesentery which was not amenable to surgical resection. A biopsy of this mass was taken, which demonstrated that it was a lymphangioma. A low fat MCT diet and tight bandaging of the aff ected limbs have since largely controlled the symptoms of limb swelling and diarrhoea. The mass is reducing spontaneously. He recently required two 100 ml transfusions of 20 % albumin solution but currently keeps well, free of infection and has good function of his limbs.
Case 3
A 3 day-old female was hospitalised due to progressive abdominal distension and respiratory distress. There were no signs of intestinal obstruction. Abdominal ultrasonography revealed an abdominal multi-loculated, septated cystic mass fi lling the whole abdominal cavity. On abdominal CT, the mass was found to consist of multi-loculated cysts with septations, extending towards the retroperitoneum and displacing the abdominal viscera. At exploration, the multi-loculated mass was found to originate from the retroperitoneum, extending towards the mesentery and left colon. Marsupialisation was performed to avoid age-related life-threatening surgical complications. During postoperative care, she developed ascites, leaking from the serosal surface of the intestines, leading to further respiratory distress. US examination revealed widespread accumulation of free fl uid between intestinal loops. The patient was started on TPN, and a high protein, low fat diet supplemented with MCT was started via a nasogastric tube. She had a low plasma albumin (27Gm / Lt) level with normal IgG (1020 mg / dl), low Ig A (27 mg / dl) and IgM (12.3 mg / dl) levels. Tcell series were not studied. A total of eight abdominal paracenteses were performed during the one month follow-up period. The patient tolerated these repeated procedures well, showing no sign of clinical and laboratory deterioration and did not develop any infections. A second operation revealed enlarged cysts with a marked decrease in free peritoneal fl uid. A left hemicolectomy with partial retroperitone was feasible this time. Table 2 ) &
Results ( • ▶
In the 55 cases studied, 2 groups emerged: 1) Group A consisted of 27 patients, including 3 of our own, who were treated with dietary changes and MCT in their diet; 2) Group B consisted of 28 patients treated without MCT in their feeds and subjected to a variety of treatments such as a wait-and-watch policy with compression bandages or diuretic therapy [4] , albumin transfusions [18] , anti-plasmin therapy [27] , lymphatic-venous anastomosis [7] , a peritoneovenous (LeVeen) shunt [3] and resection of isolated segments of aff ected bowel [3, 47] , or octreotide therapy. Discussion & Lymphatic disorders can be classifi ed into primary and secondary groups, depending on their aetiology [6 -8, 20 -22, 30, 31] . Primary disorders are those of a congenital nature and are the result of malformation of the lymphatic system. Secondary disorders are the result of an external pathology which aff ects the lymphatics or lymph nodes, e.g. malignancy, fi brosis, trauma. Primary lymphatic malformations are a spectrum of disorders which present with symptoms related to their anatomical site and severity [7, 8] ( • ▶ Table 3 ). Primary intestinal lymphangiectasia (PIL) is one such condition which, not surprisingly, may coexist with other lymphatic anomalies [7, 9, 20, 25, 28, 30 -33] . In addition to other lymphatic anomalies, PIL has been recorded in association with several other clinical syndromes [9, 34 -40] . Since Waldmann et al. [4] reported their series in 1961, there have been many articles which have contributed to the collective knowledge of the condition, such as the method of protein loss [8, 19] , the eff ects on gammaglobulin metabolism [5] , lymphocyte populations and their function [16, 24, 41] , incidences of familial clustering [3, 32, 42] , and endoscopic appearance [43] .
Reports of a functional form of PIL with its characteristic endoscopic appearance and pathological confi rmation of dilated lymphatics but without clinical symptoms have also recently emerged. These patients were identifi ed during routine endoscopy for other unrelated conditions and were found to remain asymptomatic on subsequent follow-up [44 -46] . Wireless capsule endoscopy (WCE) and 99mTc human serum albumin scans have been used more recently for diagnosis in patients with a protein-losing enteropathy [47, 48] . In a recent study, WCE was able to identify patchy lymphangiectasia in all 4 suspected cases [47] . Tc 99m-labelled human serum albumin has also been used to confi rm the diagnosis. However, it is not a good tool to assess the extent of the disease and to plan surgery [48] . In 1963, Stoelinga et al. [18] studied the eff ects of dietary fat on the serum protein levels in a patient aff ected by IL. They recorded an improvement in the clinical symptoms and protein levels on a low fat diet. Of particular interest was the observation that 15 hours after ingestion of coconut oil, triglycerides with chain length 12C (lauric acid) and above remained in the duodenal lumen, while no traces of the low molecular weight triglycerides were detected. Furthermore, the quality of life was improved by the restriction of dietary fat and the use of MCT [19, 25, 26, 29, 33] .
This was accompanied by a reduction in gastrointestinal protein loss, an increase in serum protein levels and importantly for patients, obvious clinical remission, if not resolution of symptoms. However these studies only reported the short-term benefi ts of MCT. Lloyd et al. followed six patients for between 3 and 8 years, observing the response to the MCT diet [33] . They found that there was a marked symptomatic relief (except for asymmetrical oedema due to other lymphatic anomalies) which was accompanied by an improvement in growth rate in all patients. However, evidence of clinical and biochemical relapse was quickly seen when the diet was relaxed in 3 of 4 patients. They concluded that MCT is a good source of high energy food within a low fat diet and that most patients would require the therapy for life.
Other additional types of therapy have been investigated and have proved useful in specifi c patients and circumstances. These include diuretic therapy [4] , albumin transfusions [18] , antiplasmin therapy [27] , lymphatic-venous anastomosis [7] , a peritoneovenous (LeVeen) shunt [3] and resection of isolated segments of aff ected bowel [3, 47] . Octreotide therapy, a somatostatin analogue, is a recent promising modality, especially when a low fat diet with MCT is ineff ective [49] . However some experimental studies have not been able to demonstrate the benefi ts [50] . The principle treatment for patients with diff use disease and marked protein loss appears to be a low fat MCT diet [6, 7, 20, 25, 33] . It is clear from our review that a low fat, MCT-supplemented diet is not a panacea and not all patients respond equally well. Seventeen had complete resolution of symptoms and 6 had some improvement -this latter category ranged from slight to major changes in symptomatology. Two patients were unable to tolerate it due to nausea which would appear to be the only significant side eff ect [27, 28] . One patient in our review experienced no improvement [24] , and one died despite therapy [31] .
Other problems related to the diet are that the families have to be taught to cook within its confi nes. The oil has a strong odour, a tendency to smoke, is extremely fl ammable and is relatively expensive. Commercial preparations for nasogastric feeding are now available which help overcome some of these problems and enable the patient to receive a high energy food source. Our patients have demonstrated many of the features of intestinal lymphangiectasia. Their symptomatic response to the diet was similar to other patients highlighted by our literature review. However, the improvement in growth parameters seen by Lloyd et al. was not evident in these cases.
Conclusions &
Despite continuing advances in our knowledge of primary intestinal lymphangiectasia, there has not been similarly proven progress in therapy. This is not surprising since the pathology is a congenital abnormality of the lymphatic system. Medium chain triglycerides have certainly made a signifi cant diff erence to the quality of life of many patients and our fi ndings would support their use as the primary therapeutic option in the management of this condition. 
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